Foghorn Therapeutics exec sells over $116k in company stock, a move that has sparked curiosity and raised questions about the company’s future. The sale, which occurred on [Date of Sale], involved [Number of Shares] shares at a price of [Price Per Share], totaling over $116,000. While this transaction might seem …
Read More »
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.